542 related articles for article (PubMed ID: 25869387)
1. Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.
Filatenkov A; Baker J; Mueller AM; Kenkel J; Ahn GO; Dutt S; Zhang N; Kohrt H; Jensen K; Dejbakhsh-Jones S; Shizuru JA; Negrin RN; Engleman EG; Strober S
Clin Cancer Res; 2015 Aug; 21(16):3727-39. PubMed ID: 25869387
[TBL] [Abstract][Full Text] [Related]
2. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting the CD8
Chen HY; Xu L; Li LF; Liu XX; Gao JX; Bai YR
Sci Rep; 2018 Aug; 8(1):11934. PubMed ID: 30093664
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation.
Liu J; Zhou J; Wu M; Hu C; Yang J; Li D; Wu P; Chen Y; Chen P; Lin S; Cui Y; Fu S; Wu J
Front Immunol; 2019; 10():317. PubMed ID: 30873170
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW
Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal oxaliplatin administration inhibits the tumor immunosuppressive microenvironment in an abdominal implantation model of colon cancer.
Gou HF; Zhou L; Huang J; Chen XC
Mol Med Rep; 2018 Aug; 18(2):2335-2341. PubMed ID: 29956798
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer.
Ma YF; Ren Y; Wu CJ; Zhao XH; Xu H; Wu DZ; Xu J; Zhang XL; Ji Y
Mol Immunol; 2016 Jul; 75():11-20. PubMed ID: 27209087
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.
Hossain F; Al-Khami AA; Wyczechowska D; Hernandez C; Zheng L; Reiss K; Valle LD; Trillo-Tinoco J; Maj T; Zou W; Rodriguez PC; Ochoa AC
Cancer Immunol Res; 2015 Nov; 3(11):1236-47. PubMed ID: 26025381
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
[TBL] [Abstract][Full Text] [Related]
12. Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells.
Kulzer L; Rubner Y; Deloch L; Allgäuer A; Frey B; Fietkau R; Dörrie J; Schaft N; Gaipl US
J Immunotoxicol; 2014 Oct; 11(4):328-36. PubMed ID: 24512329
[TBL] [Abstract][Full Text] [Related]
13. Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions.
Dutt S; Atallah MB; Minamida Y; Filatenkov A; Jensen KP; Iliopoulou BP; Tamosiuniene R; Waters J; Engleman EG; Strober S
Blood Adv; 2018 Oct; 2(19):2568-2580. PubMed ID: 30301812
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
16. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous inoculation position affects the immune environment in CT26 carcinomas.
Fu X; Yang Y; Xie J; Pan X; Yang X; Du Z; Hao E
Biochem Biophys Res Commun; 2019 Apr; 512(2):244-249. PubMed ID: 30879760
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene.
Wojas-Turek J; Pajtasz-Piasecka E; Rossowska J; Piasecki E; Duś D
Folia Histochem Cytobiol; 2012 Oct; 50(3):414-9. PubMed ID: 23042272
[TBL] [Abstract][Full Text] [Related]
19. MHC class II-KO mice are resistant to the immunosuppressive effects of UV light.
Krasteva M; Aubin F; Laventurier S; Kehren J; Assossou O; Kanitakis J; Kaiserlian D; Nicolas JF
Eur J Dermatol; 2002; 12(1):10-9. PubMed ID: 11809589
[TBL] [Abstract][Full Text] [Related]
20. Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
Spina CS; Tsuruoka C; Mao W; Sunaoshi MM; Chaimowitz M; Shang Y; Welch D; Wang YF; Venturini N; Kakinuma S; Drake CG
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):813-818. PubMed ID: 33190969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
